Osaka, Japan

Cesar Aguirre Martinez

This inventor holds 1 USPTO granted patent. Top assignee: Osaka University. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cesar Aguirre Martinez. Retrieved from https://idiyas.com/inventor/cesar-aguirre-martinez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Cesar Aguirre Martinez in Neurodegenerative Disease Diagnosis.

Introduction

Cesar Aguirre Martinez is an accomplished inventor based in Osaka, Japan. He has made significant contributions to the field of neurodegenerative disease diagnosis, particularly in differentiating between Parkinson's disease and multiple system atrophy. His innovative approach has the potential to improve diagnostic accuracy and patient outcomes.

Latest Patents

Cesar Aguirre Martinez holds a patent for a method and kit designed to discriminate between Parkinson's disease and multiple system atrophy. The patent outlines a systematic approach that includes preparing a solution containing α-synuclein monomers, adding a biological sample from a subject, allowing the monomers to aggregate, and detecting the resulting α-synuclein aggregates. This method represents a significant advancement in the diagnostic process for these complex conditions.

Career Highlights

Cesar Aguirre Martinez is affiliated with Osaka University, where he conducts research and develops innovative diagnostic methods. His work has garnered attention for its potential to enhance the understanding and treatment of neurodegenerative diseases. With a focus on practical applications, he aims to bridge the gap between research and clinical practice.

Collaborations

Cesar has collaborated with notable colleagues, including Hideki Mochizuki and Keita Kakuda. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further advancing the field of neurodegenerative disease research.

Conclusion

Cesar Aguirre Martinez's contributions to the diagnosis of neurodegenerative diseases highlight the importance of innovation in medical research. His patented method offers a promising avenue for improving diagnostic accuracy and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…